Lexaria Bioscience Corp (LEXX)
2.07
-0.09
(-4.17%)
USD |
NASDAQ |
Nov 22, 16:00
2.07
0.00 (0.00%)
After-Hours: 19:30
Lexaria Bioscience Total Assets (Quarterly): 10.02M for May 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| May 31, 2024 | 10.02M |
| February 29, 2024 | 6.352M |
| November 30, 2023 | 3.627M |
| August 31, 2023 | 3.084M |
| May 31, 2023 | 5.240M |
| February 28, 2023 | 4.855M |
| November 30, 2022 | 6.214M |
| August 31, 2022 | 7.834M |
| May 31, 2022 | 9.138M |
| February 28, 2022 | 11.41M |
| November 30, 2021 | 11.75M |
| August 31, 2021 | 13.27M |
| May 31, 2021 | 10.55M |
| February 28, 2021 | 12.17M |
| November 30, 2020 | 2.174M |
| August 31, 2020 | 2.828M |
| May 31, 2020 | 3.320M |
| February 29, 2020 | 1.986M |
| November 30, 2019 | 2.746M |
| August 31, 2019 | 2.675M |
| May 31, 2019 | 3.457M |
| February 28, 2019 | 4.274M |
| November 30, 2018 | 3.544M |
| August 31, 2018 | 2.432M |
| May 31, 2018 | 2.709M |
| Date | Value |
|---|---|
| February 28, 2018 | 2.841M |
| November 30, 2017 | 2.497M |
| August 31, 2017 | 2.860M |
| May 31, 2017 | 3.144M |
| February 28, 2017 | 0.8691M |
| November 30, 2016 | 1.137M |
| August 31, 2016 | 0.5666M |
| May 31, 2016 | 0.3313M |
| February 29, 2016 | 0.3894M |
| November 30, 2015 | 0.4961M |
| August 31, 2015 | 0.7117M |
| May 31, 2015 | 1.199M |
| February 28, 2015 | 1.210M |
| November 30, 2014 | 2.251M |
| July 31, 2014 | 4.566M |
| April 30, 2014 | 4.838M |
| January 31, 2014 | 3.560M |
| October 31, 2013 | 3.573M |
| July 31, 2013 | 3.683M |
| April 30, 2013 | 3.799M |
| January 31, 2013 | 3.923M |
| October 31, 2012 | 4.192M |
| July 31, 2012 | 4.224M |
| April 30, 2012 | 4.131M |
| January 31, 2012 | 4.228M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.986M
Minimum
Feb 2020
13.27M
Maximum
Aug 2021
6.766M
Average
6.214M
Median
Nov 2022
Total Assets (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 549.36M |
| Edesa Biotech Inc | 5.228M |
| Xenon Pharmaceuticals Inc | 835.90M |
| ESSA Pharma Inc | 132.67M |
| ImmunoPrecise Antibodies Ltd | 42.81M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 0.2714M |
| Shareholders Equity (Quarterly) | 10.12M |
| Current Ratio | 58.27 |